The DOI matches its Crossref record.
Updated New Zealand cardiovascular disease risk-benefit prediction guide
Open accessAbstract
Abstract Addition of HER2-targeted agents to neoadjuvant chemotherapy has dramatically improved pathological complete response (pCR) rates in early stage Human epidermal growth factor receptor 2 (HER2)-positive breast cancer. Still, up to 50% of patients have residual disease following treatment and biomarkers predictive of response are urgently needed. We performed spatial proteomic characterization using NanoString GeoMX Digital Spatial Profiling (DSP) of 122 samples from 57 HER2-positive breast tumors from the neoadjuvant TRIO-US B07 clinical trial (discovery cohort, n=28; validation cohort, n=29) sampled pre-treatment, after 14-21 days of HER2-targeted therapy and at surgery. In situ quantification of 40 tumor and immune proteins across multiple pancytokeratin-enriched regions per sample revealed that treatment results in decreased HER2 signaling and increased immune infiltration after several weeks of therapy. These changes were more dramatic in tumors that ultimately undergo pCR, and a classifier trained to predict pCR using on-treatment and pre-treatment DSP protein levels had a cross-validation mean Area Under the Receiver Operating Characteristics (AUROC) of 0.733 in the discovery cohort and validated in an independent cohort (AUROC = 0.725). Thus, we demonstrate robust stratification of sensitive tumors early during neoadjuvant HER2-targeted therapy using a multiplex spatial proteomic biomarker with implications for tailoring subsequent therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
(2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00002 · Cited by 2,672
Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S., Rumberger, J., Badimon, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087481.55887.c9 · Cited by 2,668
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan, R. S. (2006) · Circulation · doi:10.1161/circulationaha.104.482570 · Cited by 1,212
Cardiovascular Risk Prediction: Basic Concepts, Current Status, and Future Directions
Lloyd-Jones, D. M. (2010) · Circulation · doi:10.1161/circulationaha.109.849166 · Cited by 705
(2014) · The Lancet · doi:10.1016/s0140-6736(14)61212-5 · Cited by 623
Predictive accuracy of the Framingham coronary risk score in British men:prospective cohort study
Brindle, P., Jonathan, E., Lampe, F., Walker, M., Whincup, P., Fahey, T., & Ebrahim, S. (2003) · BMJ · doi:10.1136/bmj.327.7426.1267 · Cited by 525
Jackson, R., Lawes, C. M., Bennett, D. A., Milne, R. J., & Rodgers, A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17833-7 · Cited by 519
Self-citationBrindle, P., Beswick, A., Fahey, T., & Ebrahim, S. (2006) · Heart · doi:10.1136/hrt.2006.087932 · Cited by 452
Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase Inhibitors
Williams, D., & Feely, J. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241050-00003 · Cited by 423
An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas
Marrugat, J., D’Agostino, R., Sullivan, L., Elosua, R., Wilson, P., Ordovas, J., Solanas, P., Cordón, F., Ramos, R., Sala, J., et al. (2003) · Journal of Epidemiology and Community Health · doi:10.1136/jech.57.8.634 · Cited by 371
Mendis, S., Lindholm, L. H., Mancia, G., Whitworth, J., Alderman, M., Lim, S., & Heagerty, T. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282861fd3 · Cited by 332
Sempos, C. T., Heijboer, A. C., Bikle, D. D., Bollerslev, J., Bouillon, R., Brannon, P. M., DeLuca, H. F., Jones, G., Munns, C. F., Bilezikian, J. P., et al. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13652 · Cited by 331
Cardiovascular Disease Risk Assessment: Insights from Framingham
D’Agostino Sr., R. B., Pencina, M. J., Massaro, J. M., & Coady, S. (2013) · Global Heart · doi:10.1016/j.gheart.2013.01.001 · Cited by 329
Dhingra, R., & Vasan, R. S. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.11.003 · Cited by 315
From subgroups to individuals: general principles and the example of carotid endarterectomy
Rothwell, P. M., Mehta, Z., Howard, S. C., Gutnikov, S. A., & Warlow, C. P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17746-0 · Cited by 281
Mortality Risk Score Prediction in an Elderly Population Using Machine Learning
Rose, S. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws241 · Cited by 193
Sheridan, S., Pignone, M., & Mulrow, C. (2003) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2003.30107.x · Cited by 178
Development of life-expectancy tables for people with type 2 diabetes
Leal, J., Gray, A. M., & Clarke, P. M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn567 · Cited by 128
“The chosen age groups, smoking status, and the range of values for SBP and ratio of total:HDL cholesterol were similar to those reported in previous cardiovascular risk prediction charts.(10,21) The HBA1c values were selected to capture a large proportion of people with type 2 diabetes.”
BackgroundResultBarriers to implementing cardiovascular risk tables in routine general practice
Steenkiste, B. V., Weijden, T. V. D., Stoffers, H. E. J. H., & Grol, R. (2004) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430310004489 · Cited by 104
Bittencourt, M. S., Blaha, M. J., Blankstein, R., Budoff, M., Vargas, J. D., Blumenthal, R. S., Agatston, A. S., & Nasir, K. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1640 · Cited by 70
“Accordingly, the NNT for 5 years to reduce 1 CVD event decreased to 18 to 20, which is much lower than the threshold used to recommend the treatment of hypertension (19,20) or for the use of statins in primary”
Metadata
- Authors
- Jackson, R.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2000-03-11
- Volume
- 320
- Issue
- 7236
- Pages
- 709-710
- ISSN
- 0959-8138 (ISSN-L)
- OpenAlex
- W1986010116
- Cited by
- 229
- References
- 0
- FWCI
- 5.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.